{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T08:23:10Z","timestamp":1791015790227,"version":"4.1.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,10,16]]},"DOI":"10.7759\/cureus.47129","type":"journal-article","created":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T14:26:21Z","timestamp":1697466381000},"source":"Crossref","is-referenced-by-count":13,"title":["Alport Syndrome: A Comprehensive Review"],"prefix":"10.7759","author":[{"given":"Avanti","family":"Adone","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashish","family":"Anjankar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-00354-y","article-title":"Creation of X-linked Alport syndrome rat model with Col4a5 deficiency","volume":"11","author":"Namba M","year":"2021","unstructured":"Namba M, Kobayashi T, Kohno M, Koyano T, Hirose T, Fukushima M, Matsuyama M. Creation of X-linked Alport syndrome rat model with Col4a5 deficiency. Sci Rep. 2021, 11:20836. 10.1038\/s41598-021-00354-y","journal-title":"Sci Rep"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2017.12.018","article-title":"Alport syndrome: a unified classification of genetic disorders of collagen IV \u03b1345: a position paper of the Alport Syndrome Classification Working Group","volume":"93","author":"Kashtan CE","year":"2018","unstructured":"Kashtan CE, Ding J, Garosi G, et al.. Alport syndrome: a unified classification of genetic disorders of collagen IV \u03b1345: a position paper of the Alport Syndrome Classification Working Group. Kidney Int. 2018, 93:1045-51. 10.1016\/j.kint.2017.12.018","journal-title":"Kidney Int"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2020.03.026","article-title":"Alport syndrome: achieving early diagnosis and treatment","volume":"77","author":"Kashtan CE","year":"2021","unstructured":"Kashtan CE. Alport syndrome: achieving early diagnosis and treatment. Am J Kidney Dis. 2021, 77:272-9. 10.1053\/j.ajkd.2020.03.026","journal-title":"Am J Kidney Dis"},{"key":"ref4","article-title":"Alport syndrome: clinical update","volume":"6","author":"Wester DC","year":"1995","unstructured":"Wester DC, Atkin CL, Gregory MC. Alport syndrome: clinical update. J Am Acad Audiol. 1995, 6:73-9.","journal-title":"J Am Acad Audiol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-020-04819-6","article-title":"Clinical practice recommendations for the diagnosis and management of Alport syndrome in children, adolescents, and young adults-an update for 2020","volume":"36","author":"Kashtan CE","year":"2021","unstructured":"Kashtan CE, Gross O. Clinical practice recommendations for the diagnosis and management of Alport syndrome in children, adolescents, and young adults-an update for 2020. Pediatr Nephrol. 2021, 36:711-9. 10.1007\/s00467-020-04819-6","journal-title":"Pediatr Nephrol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1038\/eye.1987.21","article-title":"Ocular signs in Alport's syndrome","volume":"1","author":"Thompson SM","year":"1987","unstructured":"Thompson SM, Deady JP, Willshaw HE, White RH. Ocular signs in Alport's syndrome. Eye (Lond). 1987, 1:146-53. 10.1038\/eye.1987.21","journal-title":"Eye (Lond)"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.03120322","article-title":"Digenic Alport syndrome","volume":"17","author":"Savige J","year":"2022","unstructured":"Savige J, Renieri A, Ars E, et al.. Digenic Alport syndrome. Clin J Am Soc Nephrol. 2022, 17:1697-706. 10.2215\/CJN.03120322","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1126\/science.2349482","article-title":"Identification of mutations in the COL4A5 collagen gene in Alport syndrome","volume":"248","author":"Barker DF","year":"1990","unstructured":"Barker DF, Hostikka SL, Zhou J, et al.. Identification of mutations in the COL4A5 collagen gene in Alport syndrome. Science. 1990, 248:1224-7. 10.1126\/science.2349482","journal-title":"Science"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1111\/nep.13115","article-title":"Autosomal dominant form of type IV collagen nephropathy exists among patients with hereditary nephritis difficult to diagnose clinicopathologically","volume":"23","author":"Imafuku A","year":"2018","unstructured":"Imafuku A, Nozu K, Sawa N, et al.. Autosomal dominant form of type IV collagen nephropathy exists among patients with hereditary nephritis difficult to diagnose clinicopathologically. Nephrology (Carlton). 2018, 23:940-7. 10.1111\/nep.13115","journal-title":"Nephrology (Carlton)"},{"key":"ref10","article-title":"Alport syndrome","author":"Kashtan CE","year":"2019","unstructured":"Kashtan CE. Alport syndrome. GeneReviews\u00ae [Internet]. Adam MP, Mirzaa GM, Pagon RA, et al. (ed): University of Washington, Seattle (WA); 2019."},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.04230321","article-title":"Guidelines for genetic testing and management of Alport syndrome","volume":"17","author":"Savige J","year":"2022","unstructured":"Savige J, Lipska-Zietkiewicz BS, Watson E, et al.. Guidelines for genetic testing and management of Alport syndrome. Clin J Am Soc Nephrol. 2022, 17:143-54. 10.2215\/CJN.04230321","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.23876\/j.krcp.20.111","article-title":"Genetic background, recent advances in molecular biology, and development of novel therapy in Alport syndrome","volume":"39","author":"Nozu K","year":"2020","unstructured":"Nozu K, Takaoka Y, Kai H, et al.. Genetic background, recent advances in molecular biology, and development of novel therapy in Alport syndrome. Kidney Res Clin Pract. 2020, 39:402-13. 10.23876\/j.krcp.20.111","journal-title":"Kidney Res Clin Pract"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1007\/s10157-018-1629-4","article-title":"A review of clinical characteristics and genetic backgrounds in Alport syndrome","volume":"23","author":"Nozu K","year":"2019","unstructured":"Nozu K, Nakanishi K, Abe Y, et al.. A review of clinical characteristics and genetic backgrounds in Alport syndrome. Clin Exp Nephrol. 2019, 23:158-68. 10.1007\/s10157-018-1629-4","journal-title":"Clin Exp Nephrol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2021.04.017","article-title":"Pathogenic variants in the genes affected in Alport syndrome (COL4A3-COL4A5) and their association with other kidney conditions: a review","volume":"78","author":"Savige J","year":"2021","unstructured":"Savige J, Harraka P. Pathogenic variants in the genes affected in Alport syndrome (COL4A3-COL4A5) and their association with other kidney conditions: a review. Am J Kidney Dis. 2021, 78:857-64. 10.1053\/j.ajkd.2021.04.017","journal-title":"Am J Kidney Dis"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1993.8","article-title":"Molecular genetics of Alport syndrome","volume":"43","author":"Tryggvason K","year":"1993","unstructured":"Tryggvason K, Zhou J, Hostikka SL, Shows TB. Molecular genetics of Alport syndrome. Kidney Int. 1993, 43:38-44. 10.1038\/ki.1993.8","journal-title":"Kidney Int"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.01380217","article-title":"Anti-glomerular basement membrane disease","volume":"12","author":"McAdoo SP","year":"2017","unstructured":"McAdoo SP, Pusey CD. Anti-glomerular basement membrane disease. Clin J Am Soc Nephrol. 2017, 12:1162-72. 10.2215\/CJN.01380217","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref17","article-title":"Alport syndrome. Molecular genetic aspects","volume":"56","author":"Hertz JM","year":"2009","unstructured":"Hertz JM. Alport syndrome. Molecular genetic aspects. Dan Med Bull. 2009, 56:105-52.","journal-title":"Dan Med Bull"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.10581014","article-title":"Ocular features in Alport syndrome: pathogenesis and clinical significance","volume":"10","author":"Savige J","year":"2015","unstructured":"Savige J, Sheth S, Leys A, Nicholson A, Mack HG, Colville D. Ocular features in Alport syndrome: pathogenesis and clinical significance. Clin J Am Soc Nephrol. 2015, 10:703-9. 10.2215\/CJN.10581014","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2021.02.326","article-title":"Clinical and genetic features of autosomal dominant Alport syndrome: a cohort study","volume":"78","author":"Furlano M","year":"2021","unstructured":"Furlano M, Mart\u00ednez V, Pybus M, et al.. Clinical and genetic features of autosomal dominant Alport syndrome: a cohort study. Am J Kidney Dis. 2021, 78:560-70.e1. 10.1053\/j.ajkd.2021.02.326","journal-title":"Am J Kidney Dis"},{"key":"ref20","article-title":"A mutation causing Alport syndrome with tardive hearing loss is common in the western United States","volume":"58","author":"Barker DF","year":"1996","unstructured":"Barker DF, Pruchno CJ, Jiang X, et al.. A mutation causing Alport syndrome with tardive hearing loss is common in the western United States. Am J Hum Genet. 1996, 58:1157-65.","journal-title":"Am J Hum Genet"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.3980\/j.issn.2222-3959.2010.02.13","article-title":"Ocular manifestations of Alport syndrome","volume":"3","author":"Xu JM","year":"2010","unstructured":"Xu JM, Zhang SS, Zhang Q, Zhou YM, Zhu CH, Ge J, Wang L. Ocular manifestations of Alport syndrome. Int J Ophthalmol. 2010, 3:149-51. 10.3980\/j.issn.2222-3959.2010.02.13","journal-title":"Int J Ophthalmol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.V114649","article-title":"X-linked Alport syndrome: natural history in 195 families and genotype- phenotype correlations in males","volume":"11","author":"Jais JP","year":"2000","unstructured":"Jais JP, Knebelmann B, Giatras I, et al.. X-linked Alport syndrome: natural history in 195 families and genotype- phenotype correlations in males. J Am Soc Nephrol. 2000, 11:649-57. 10.1681\/ASN.V114649","journal-title":"J Am Soc Nephrol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1136\/jmedgenet-2014-102822","article-title":"Evidence of digenic inheritance in Alport syndrome","volume":"52","author":"Mencarelli MA","year":"2015","unstructured":"Mencarelli MA, Heidet L, Storey H, et al.. Evidence of digenic inheritance in Alport syndrome. J Med Genet. 2015, 52:163-74. 10.1136\/jmedgenet-2014-102822","journal-title":"J Med Genet"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.9636.1","article-title":"Alport syndrome: facts and opinions","volume":"6","author":"Kashtan C","year":"2017","unstructured":"Kashtan C. Alport syndrome: facts and opinions. F1000Res. 2017, 6:50. 10.12688\/f1000research.9636.1","journal-title":"F1000Res"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-018-3985-4","article-title":"Expert consensus guidelines for the genetic diagnosis of Alport syndrome","volume":"34","author":"Savige J","year":"2019","unstructured":"Savige J, Ariani F, Mari F, et al.. Expert consensus guidelines for the genetic diagnosis of Alport syndrome. Pediatr Nephrol. 2019, 34:1175-89. 10.1007\/s00467-018-3985-4","journal-title":"Pediatr Nephrol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1081\/jdi-100101961","article-title":"Contemporary diagnostic approach in Alport's syndrome","volume":"22","author":"Gr\u00fcnfeld JP","year":"2000","unstructured":"Gr\u00fcnfeld JP. Contemporary diagnostic approach in Alport's syndrome. Ren Fail. 2000, 22:759-63. 10.1081\/jdi-100101961","journal-title":"Ren Fail"},{"key":"ref27","article-title":"Clinical and molecular diagnosis of Alport syndrome","volume":"107","author":"Kashtan CE","year":"1995","unstructured":"Kashtan CE. Clinical and molecular diagnosis of Alport syndrome. Proc Assoc Am Physicians. 1995, 107:306-13.","journal-title":"Proc Assoc Am Physicians"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-006-0376-z","article-title":"Diagnosis of Alport syndrome without biopsy?","volume":"22","author":"Gubler MC","year":"2007","unstructured":"Gubler MC. Diagnosis of Alport syndrome without biopsy?. Pediatr Nephrol. 2007, 22:621-5. 10.1007\/s00467-006-0376-z","journal-title":"Pediatr Nephrol"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-012-2138-4","article-title":"Clinical practice recommendations for the treatment of Alport syndrome: a statement of the Alport Syndrome Research Collaborative","volume":"28","author":"Kashtan CE","year":"2013","unstructured":"Kashtan CE, Ding J, Gregory M, et al.. Clinical practice recommendations for the treatment of Alport syndrome: a statement of the Alport Syndrome Research Collaborative. Pediatr Nephrol. 2013, 28:5-11. 10.1007\/s00467-012-2138-4","journal-title":"Pediatr Nephrol"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.5527\/wjn.v3.i4.230","article-title":"Searching for a treatment for Alport syndrome using mouse models","volume":"3","author":"Katayama K","year":"2014","unstructured":"Katayama K, Nomura S, Tryggvason K, Ito M. Searching for a treatment for Alport syndrome using mouse models. World J Nephrol. 2014, 3:230-6. 10.5527\/wjn.v3.i4.230","journal-title":"World J Nephrol"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.3760\/cma.j.issn.0578-1310.2016.09.008","article-title":"Analysis of diagnosis and treatment of Alport syndrome [Article in Chinese]","volume":"54","author":"An XG","year":"2016","unstructured":"An XG, Zhang YQ, Ding J, Wang F, Xiao HJ, Yao Y. Analysis of diagnosis and treatment of Alport syndrome [Article in Chinese]. Zhonghua Er Ke Za Zhi. 2016, 54:669-73. 10.3760\/cma.j.issn.0578-1310.2016.09.008","journal-title":"Zhonghua Er Ke Za Zhi"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1113\/jphysiol.2014.274449","article-title":"Alport syndrome: its effects on the glomerular filtration barrier and implications for future treatment","volume":"592","author":"Savige J","year":"2014","unstructured":"Savige J. Alport syndrome: its effects on the glomerular filtration barrier and implications for future treatment. J Physiol. 2014, 592:4013-23. 10.1113\/jphysiol.2014.274449","journal-title":"J Physiol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/176310-alport-syndrome-a-comprehensive-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:05:34Z","timestamp":1707509134000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/176310-alport-syndrome-a-comprehensive-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,16]]},"references-count":32,"URL":"https:\/\/doi.org\/10.7759\/cureus.47129","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10,16]]}}}